Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder
Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder
复制标题
DOI：
10.1016/j.jacc.2004.12.072
复制
发表时间：
2005-04-19
影响因子：
24
通讯作者：
Ducas, J
中科院分区：
文献类型：
--
作者：
Divekar, A;Gaamangwe, T;Ducas, J
Amplatzer间隔封堵器（阿索）相关的心脏穿孔（CP）在我们的机构促使这一回顾性review.Background心脏穿孔是一种罕见的并发症后，经导管房间隔缺损（ASD）closed.METHODS确定CP后，经导管房间隔缺损封堵器，心脏事件（CE）描述明确CP，心包积血，心包积液，心血管塌陷，或猝死进行了分析。从已发表文献（MEDLINE）、北美医疗器械监管机构和欧盟委员会以及阿加医疗公司（Golden Valley，Minnesota）中识别心脏事件。对机构案件进行了审查。心脏事件被定义为早期（出院前）或晚期（出院后）。结果确定了29起CE。5例被排除，因为器械相关CP的结果不确定。10名患者
OBJECTIVES Amplatzer septal occluder (ASO)-associated cardiac perforation (CP) at our institution prompted this retrospective review.BACKGROUND Cardiac perforation is a rare complication after transcatheter atrial septal defect (ASD) closure.METHODS To identify CP after transcatheter ASD closure with ASO, cardiac events (CE) describing definite CP, hemopericardium, pericardial effusion, cardiovascular collapse, or sudden death were analyzed. Cardiac events were identified from published literature (MEDLINE), medical device regulating agencies in North America and the European Commission, and AGA Medical Corporation (Golden Valley, Minnesota). Institutional cases were reviewed. Cardiac events were defined as early (pre-discharge) or late (post-discharge).RESULTS Twenty-nine CEs were identified. Five were excluded because findings were inconclusive for device-related CP. Ten patients were